Literature DB >> 29185158

Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.

Vanathi Perumal1, Frank Arfuso2, Yan Chen3, Simon Fox1, Arun M Dharmarajan4.   

Abstract

In malignant mesothelioma (MM) cells, secreted frizzled-related protein 4 (SFRP4) expression is downregulated by promoter methylation. In this study, we evaluated the effect of encapsulated chitosan-dextran (CS-DS) nanoparticle formulations of SFRP4 and its cysteine-rich domain (CRD) and netrin-like domain (NLD) as means of SFRP4-GFP protein delivery and their effects in JU77 and ONE58 MM cell lines. CS-DS formulations of SFRP4, CRD, and NLD nanoparticles were prepared by a complex coacervation technique, and particle size ranged from 300 nm for empty particles to 337 nm for particles containing the proteins. Measurement of the zeta potential showed that all preparations were around 25 mV or above, suggesting stable formulation and good affinity for the DNA molecules. The CS-DS nanoparticle formulation maintained high integrity and entrapment efficiency. Gene delivery of SFRP4 and its domains showed enhanced biological effects in both JU77 and ONE58 cell lines when compared to the non-liposomal FUGENE® HD transfection reagent. In comparison to the CRD nanoparticles, both the SFRP4 and NLD nanoparticles significantly reduced the viability of MM cells, with the NLD showing the greatest effect. The CS-DS nanoparticle effects were observed at an earlier time point and with lower DNA concentrations. Morphological changes in MM cells were characterized by the formation of membrane-associated vesicles and green fluorescent protein expression specific to SFRP4 and the NLD. The findings from our proof-of-concept study provide a stepping stone for further investigations using in vivo models.

Entities:  

Keywords:  Chitosan–dextran sulfate; Gene delivery; Mesothelioma; Secreted frizzled-related protein 4

Mesh:

Substances:

Year:  2017        PMID: 29185158     DOI: 10.1007/s11010-017-3225-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.

Authors:  Louise R Whittell; Kevin T Batty; Rina P M Wong; Erin M Bolitho; Simon A Fox; Timothy M E Davis; Paul E Murray
Journal:  Bioorg Med Chem       Date:  2011-10-20       Impact factor: 3.641

2.  Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling.

Authors:  Zofia von Marschall; Larry W Fisher
Journal:  Biochem Biophys Res Commun       Date:  2010-08-17       Impact factor: 3.575

Review 3.  Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.

Authors:  C R Dass; T M N Tran; P F M Choong
Journal:  J Dent Res       Date:  2007-10       Impact factor: 6.116

Review 4.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

5.  The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.

Authors:  Vanathi Perumal; Arun M Dharmarajan; Simon A Fox
Journal:  Int J Oncol       Date:  2017-05-18       Impact factor: 5.650

6.  Exploring advantages/disadvantages and improvements in overcoming gene delivery barriers of amino acid modified trimethylated chitosan.

Authors:  Hao Zheng; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2014-12-23       Impact factor: 4.200

7.  Secreted frizzled-related protein 4: an angiogenesis inhibitor.

Authors:  Ajit Muley; Syamantak Majumder; Gopi Krishna Kolluru; Steve Parkinson; Helena Viola; Livia Hool; Frank Arfuso; Ruth Ganss; Arun Dharmarajan; Suvro Chatterjee
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.

Authors:  Amie Y Lee; Biao He; Liang You; Sina Dadfarmay; Zhidong Xu; Julien Mazieres; Iwao Mikami; Frank McCormick; David M Jablons
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

9.  Designing chitosan-dextran sulfate nanoparticles using charge ratios.

Authors:  Yan Chen; Vellore J Mohanraj; Fang Wang; Heather A E Benson
Journal:  AAPS PharmSciTech       Date:  2007-11-30       Impact factor: 3.246

Review 10.  Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.

Authors:  Anish Babu; Rajagopal Ramesh
Journal:  Mar Drugs       Date:  2017-03-27       Impact factor: 5.118

View more
  1 in total

Review 1.  Biodegradable Polymers for Gene Delivery.

Authors:  T J Thomas; Heidar-Ali Tajmir-Riahi; C K S Pillai
Journal:  Molecules       Date:  2019-10-17       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.